IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,098,000 | +26.7% | 107,875 | +8.5% | 0.05% | +22.0% |
| Q4 2017 | $1,656,000 | -14.4% | 99,450 | +4.4% | 0.04% | -22.6% |
| Q3 2017 | $1,934,000 | +26.1% | 95,250 | -0.0% | 0.05% | +20.5% |
| Q2 2017 | $1,534,000 | +32.4% | 95,275 | +4.0% | 0.04% | +37.5% |
| Q1 2017 | $1,159,000 | -15.4% | 91,600 | -11.4% | 0.03% | -15.8% |
| Q4 2016 | $1,370,000 | -49.0% | 103,375 | -8.7% | 0.04% | -49.3% |
| Q3 2016 | $2,685,000 | -15.0% | 113,275 | +3.3% | 0.08% | -14.8% |
| Q2 2016 | $3,159,000 | -9.8% | 109,625 | +0.2% | 0.09% | -7.4% |
| Q1 2016 | $3,504,000 | -19.2% | 109,425 | +7.9% | 0.10% | -12.8% |
| Q4 2015 | $4,335,000 | +15.0% | 101,375 | -5.3% | 0.11% | +23.9% |
| Q3 2015 | $3,770,000 | -23.2% | 107,075 | +0.2% | 0.09% | -3.3% |
| Q2 2015 | $4,908,000 | +15.1% | 106,875 | +17.5% | 0.09% | +28.2% |
| Q1 2015 | $4,264,000 | – | 90,975 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $37,950,000 | 5.83% |
| Healthcare Value Capital, LLC | 200,000 | $2,530,000 | 4.33% |
| Ratan Capital Management LP | 354,400 | $4,483,000 | 2.15% |
| SECTOR GAMMA AS | 534,311 | $6,759,000 | 1.08% |
| Sivik Global Healthcare LLC | 168,030 | $2,126,000 | 0.99% |
| Schonfeld Strategic Advisors LLC | 547,157 | $6,922,000 | 0.69% |
| Iguana Healthcare Management, LLC | 100,000 | $1,265,000 | 0.63% |
| Century Capital Management, LLC | 250,716 | $3,172,000 | 0.50% |
| Fosun International Ltd | 300,000 | $3,795,000 | 0.47% |
| Atika Capital Management LLC | 39,500 | $499,000 | 0.24% |